China NMPA Product Recall - Medical magnetic resonance imaging system

Philips Medical Systems Nederland B.V. has initiated a voluntary recall of specific medical magnetic resonance imaging systems, as announced by the National Medical Products Administration (NMPA) of China. This recall, reported by Philips (China) Investment Co., Ltd., addresses a critical safety concern involving the potential for localized heating of the torso coil during patient scanning. Such heating poses a risk of harm to patients undergoing these medical imaging procedures. The regulatory oversight for this action is provided by the NMPA, as indicated by the official publication (Index No. JGXX-2024-10103, dated 2024-06-20). This voluntary recall highlights the company's proactive commitment to product safety and compliance within the regulatory framework governing medical devices in China. The document does not specify inspection dates, as this is a manufacturer-initiated recall announcement rather than a report stemming from a regulatory inspection. The required action involves the recall of the affected medical magnetic resonance imaging systems. Detailed information, including the precise models, specifications, and batches of the products implicated in this safety notice, is available in an accompanying "Medical Device Recall Event Report Form." This measure is crucial to mitigate potential risks and ensure the continued safety and efficacy of medical devices used in patient care.